AUS
NZ
UK
CA
USA
IND
Bank of Queensland Limited (ASX:BOQ) has informed the market about the expiry of two categories of unquoted equity securities—20,007 Deferred Award Rights (BOQAS) and 673,753 options (BOQAV)—which lapsed without being exercised or converted in December 2025. This update, lodged on 3 July 2026 under Appendix 3H, attributes the delayed disclosure to an administrative processing lag. BOQ confirmed satisfaction with the adequacy of its internal systems and procedures for managing securities transactions and related notifications. For investors tracking the bank’s capital structure, this cessation reduces the number of unquoted equity securities outstanding, with no consideration paid for the lapsed instruments.
Key Points
- Company: Bank of Queensland Limited (ASX:BOQ)
- 20,007 Deferred Award Rights (BOQAS) expired on 11 December 2025 without exercise or conversion
- 673,753 options (BOQAV) expired on 8 December 2025 without exercise or conversion
- Total expired securities: 693,760 across two unquoted equity classes
- BOQ acknowledged an administrative delay in processing expiration notifications
- No consideration was paid by the company for either cessation
- Following expiry, BOQ’s ordinary fully paid shares on issue stand at 661,469,455
- Investors should monitor further Appendix 3H filings as BOQ continues managing its employee equity programs
Details on Expired BOQAS Deferred Award Rights and BOQAV Options
The update outlines the termination of two separate classes of unquoted equity securities. The first, BOQAS Deferred Award Rights, comprised 20,007 securities that expired on 11 December 2025. The second, BOQAV options, totaling 673,753 securities with varying expiry dates and exercise prices, expired on 8 December 2025. Both ceased due to expiry without holder exercise or conversion.
These Deferred Award Rights and options are typically granted as part of employee remuneration or long-term incentive schemes at major financial institutions. When not exercised before expiry, these instruments lapse automatically, eliminating the potential dilution to existing shareholders. The company confirmed no cash consideration was paid to retire these instruments from its capital structure.
Reason for July 2026 Filing Despite December 2025 Expirations
A notable aspect of the update is the nearly seven-month delay between the securities’ expiry dates—8 and 11 December 2025—and the filing date of 3 July 2026. BOQ attributed this delay to administrative processing issues.
The company reassured the market by stating: "The Company is satisfied that it does have adequate systems and processes in place in connection with transactions involving the Company's securities and associated notifications." This statement applies to both cessation events. While administrative delays can occur in managing complex incentive programs, timely disclosure of capital changes is a standard regulatory expectation. BOQ’s acknowledgment and affirmation of controls suggest this was a procedural matter rather than a systemic compliance failure.
BOQ’s Capital Structure Following December 2025 Expirations
After these expirations, BOQ’s quoted equity and debt securities remain significant. The company has 661,469,455 ordinary fully paid shares on issue. It also maintains two classes of capital notes listed on the exchange: BOQPF, a Cap Note with BBSW+3.80% coupon, perpetual non-cumulative redeemable, with 2,600,000 securities outstanding; and BOQPG, with BBSW+3.40% coupon, similar terms, and 4,000,000 securities outstanding.
On the unquoted side, BOQ retains various employee incentive equity instruments, including 3,542,986 Performance Rights (BOQAAG), 2,277,264 Deferred Award Rights (BOQAY), 1,966,725 options expiring at various dates with a $9.3337 exercise price (BOQAAA), 40,956 remaining BOQAS Deferred Award Rights, 8,178,148 BOQAV options, 71,980 Deferred Award Rights (BOQAX), and 459,785 CEO and Chair Award Rights (BOQAAC). The expiry of 693,760 securities has reduced the total unquoted pool, though many potential dilutive instruments remain outstanding.
Impact of 693,760 Securities Lapsing Without Exercise
The lapse of these options and award rights means the dilution they represented will not occur. Specifically, 20,007 Deferred Award Rights and 673,753 options, totaling 693,760 instruments, were removed from BOQ’s capital structure without issuing new shares. This is a modest positive for dilution management, though small relative to BOQ’s total ordinary shares exceeding 661 million.
For holders, the lapse typically indicates the instruments were out of the money at expiry, vesting or performance conditions were unmet, or the holders did not act before expiry. The update does not specify which applied. Exercise prices for the lapsed BOQAV options were varied but not detailed.
Ongoing Employee Equity Incentive Programs at BOQ
Despite these expirations, BOQ’s unquoted equity incentive programs remain substantial. The 459,785 CEO and Chair Award Rights (BOQAAC) are notable for executive remuneration alignment. Additionally, 3,542,986 Performance Rights remain outstanding, indicating significant senior management remuneration linked to equity performance.
The presence of 8,178,148 remaining BOQAV options, even after the lapse of 673,753, shows the program’s scale and continuity. Multiple Deferred Award Rights classes (BOQAY, BOQAS, BOQAX) reflect a layered deferred compensation approach common in Australian banks. Investors should consider these when assessing potential dilution, though vesting and exercise depend on performance and market conditions.
BOQ’s Capital Notes BOQPF and BOQPG Remain Unaffected
The expirations concern only unquoted equity securities and do not affect BOQ’s listed capital notes. BOQPF, with a coupon of BBSW+3.80%, perpetual non-cumulative redeemable, and a first call date targeted for May 2027, remains outstanding with 2,600,000 securities. BOQPG, with BBSW+3.40% coupon and a first call date targeted for December 2028, has 4,000,000 securities on issue.
These hybrid capital instruments are standard for Australian banks to meet regulatory capital requirements under APRA’s framework. They are unaffected by changes in employee equity incentive programs and continue to trade independently. Income-focused investors holding these notes should note the equity instrument lapses do not impact their terms or distributions.
Context of BOQ’s Administrative Delay Relative to Disclosure Rules
ASX Listing Rules generally require timely notification of capital changes. The seven-month gap between the December 2025 expirations and July 2026 filing is notable but explained by BOQ as an administrative delay. The bank’s statement of satisfaction with its systems suggests an internal review and classification as a one-off processing issue.
Large institutions managing complex, multi-year employee equity plans can face challenges tracking and reporting expirations. BOQ’s disclosure that no consideration was paid and that the delay is administrative likely limits investor concern. However, governance-focused investors and proxy advisers may scrutinize the timeliness and accuracy of capital management disclosures at major banks.
Investor Considerations Following BOQ’s Capital Update
For investors and analysts, the immediate impact is limited since the securities have already expired and the capital table updated. Key points to watch include the 1,966,725 BOQAAA options priced at $9.3337 that remain outstanding and could become relevant depending on BOQ’s share price relative to that strike price.
Investors should also monitor for further Appendix 3H filings in case additional historical expirations were delayed in reporting. BOQ’s assurance regarding its systems provides some comfort, but the disclosure raises questions about potential catch-up notifications. Overall, BOQ’s ongoing strategic direction and transformation under current management will remain the primary focus, with this update viewed as routine capital administration rather than a strategic change.
